Misha Walker Advocates For Arthrogryposis Patients One State at a Time
https://pixabay.com/en/morning-sunrise-woman-silhouette-2243465/

Misha Walker Advocates For Arthrogryposis Patients One State at a Time

  Misha Walker and her husband Mike have spent the summer in England, meeting with families who have children with a rare condition called arthrogryposis multiplex congenita (AMC). In the…

Continue Reading Misha Walker Advocates For Arthrogryposis Patients One State at a Time
Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs
rawpixel / Pixabay

Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs

According to a story from Research & Development, increasing collaboration between a variety of different organizations is helping to propel and improve the develop of new drugs for the treatment…

Continue Reading Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs

A Gene Therapy for Wet Age-Related Macular Degeneration has Progressed to Clinical Trials

The United States Food and Drug Administration has awarded Fast Track Designation to an experimental gene therapy for the treatment of wet age-related macular degeneration. For more detailed information, you…

Continue Reading A Gene Therapy for Wet Age-Related Macular Degeneration has Progressed to Clinical Trials
Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine
geralt / Pixabay

Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

According to a story from blogs.bmj.com, the situation has been tense recently in the halls of the Cochrane Collaboration. Cochrane is a non-profit organization that involves the work of over…

Continue Reading Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation

According to a story from pm360online.com, the drug development company Cytori Therapeutics recently announced that its investigational product ATI-1123 has been granted Orphan Drug designation from the US Food and…

Continue Reading Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation
Results From a Study Investigating a Therapy For Slow Healing Bone Fractures Have Been Announced
rawpixel / Pixabay

Results From a Study Investigating a Therapy For Slow Healing Bone Fractures Have Been Announced

Bone Therapeutics, who are developing an allogeneic bone cell therapy as a treatment for delayed-union fractures of long bones, has announced the results of a Phase 1/11A study. They have…

Continue Reading Results From a Study Investigating a Therapy For Slow Healing Bone Fractures Have Been Announced
Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story
wernerdetjen / Pixabay

Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story

Three large black and white beasts rest under a shade tree to avoid the sun’s hot rays. They appear to be chewing gum, although they are really chewing their cud.…

Continue Reading Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story

Genetic Sequencing After Stem Cell Transplant Can Inform Outcomes in Myelodysplatic Syndromes

According to a story from Hematology Times, a recent study found that genetic sequencing after the completion of a hematopoietic stem cell transplant could provide doctors with vital information about…

Continue Reading Genetic Sequencing After Stem Cell Transplant Can Inform Outcomes in Myelodysplatic Syndromes
Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
allinonemovie / Pixabay

Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published

According to a story from pm360online.com, the biopharmaceutical company Insmed Incorporated recently announced that the data from its Phase 3 clinical trial of amikacin liposome inhalation suspension (ALIS). ALIS was…

Continue Reading Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases
Pexels / Pixabay

The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases

Recent medical developments have led to new drugs designed to treat rare genetic disorders. However, the high cost of many of these drugs limits the number of patients who have…

Continue Reading The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases